Neptune Technologies & Bioressources-Ord (NEPT) Receiving Somewhat Favorable Press Coverage, Report Finds
Press coverage about Neptune Technologies & Bioressources-Ord (NASDAQ:NEPT) (TSE:NTB) has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Neptune Technologies & Bioressources-Ord earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave news headlines about the biotechnology company an impact score of 46.6629867975455 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Neptune Technologies & Bioressources-Ord (NEPT) traded down 1.13% on Thursday, reaching $0.88. 35,867 shares of the company’s stock traded hands. Neptune Technologies & Bioressources-Ord has a 52 week low of $0.70 and a 52 week high of $1.36. The firm has a 50-day moving average price of $0.89 and a 200-day moving average price of $0.92. The stock has a market capitalization of $69.20 million, a price-to-earnings ratio of 13.13 and a beta of 0.89.
TRADEMARK VIOLATION WARNING: “Neptune Technologies & Bioressources-Ord (NEPT) Receiving Somewhat Favorable Press Coverage, Report Finds” was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://theolympiareport.com/2017/10/19/neptune-technologies-bioressources-ord-nept-receiving-somewhat-favorable-press-coverage-report-finds.html.
About Neptune Technologies & Bioressources-Ord
Neptune Technologies & Bioressources Inc is a solution provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids.
Receive News & Ratings for Neptune Technologies & Bioressources-Ord Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Technologies & Bioressources-Ord and related companies with Analyst Ratings Network's FREE daily email newsletter.